[1] 中华医学会肝病学分会.原发性肝癌二级预防共识(2021年版).中华肝脏病杂志, 2021, 29(3):216-226.
[2] 胡亚秋,汪妮,冉锡萍,等.评估免疫检查点抑制剂为基础的联合治疗在原发性肝癌患者中肝损伤发生情况的真实世界研究.中华肝脏病杂志, 2022, 30(1):57-62.
[3] 王鹤,董矜,鲍金凤,等.多个血液学指标联合对于甲胎蛋白阴性肝癌患者的诊断效能分析.中华医学杂志,2022,102(17):1303-1310.
[4] Geindreau M, Ghiringhelli F, Bruchard M. Vascular endothelial growth factor, a key modulator of the anti-tumor immune response. Int J Mol Sci, 2021,22(9):4871-4872.
[5] 石磊,安梓铭,冯琴.联合检测血清AFP、AFP-L3%和PIVKA-Ⅱ水平早期诊断和判断原发性肝癌患者预后临床价值探讨.实用肝脏病杂志,2023,26(3):404-407.
[6] Chen H, Pang Y, Wu J, et al. Comparison of Ga-DOTA-FAPI-04 and FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging, 2020,7(8):1820-1832.
[7] 中国抗癌协会肝癌专业委员会,中华医学会肝病学分会肝癌学组,中国抗癌协会病理专业委员会,等.原发性肝癌规范化病理诊断指南(2015年版).中华肝胆外科杂志,2015,21(3):145-151.
[8] 中华预防医学会肝胆胰疾病预防与控制专业委员会,中国研究型医院学会肝病专业委员会,中华医学会肝病学分会,等.原发性肝癌的分层筛查与监测指南(2020年版).中华肝胆外科杂志,2021,27(1):12-29.
[9] 孙文杰,高知玲,高雨佳,等.基于多层螺旋CT全肝灌注成像小肝癌射频消融术后早期血流状态变化的定量评价.中华肝脏病杂志,2020,28(6):488-493.
[10] 冉兴强,付茂勇,赵永生,等.多层螺旋CT诊断食管鳞癌新辅助化疗后T分期的价值.中华实用诊断与治疗杂志,2022,36(7):654-657.
[11] Xie F, Hong Y, Sun X, et al. Comparison of the value of conventional two-dimensional ultrasound, contrast-enhanced ultrasound and MSCT in early diagnosis of small hepatocellular carcinoma. Minerva Gastroenterol (Torino), 2023,69(1):162-165.
[12] 彭楠,马爱珍,史展,等.CT扫描三维重建技术在巨块型原发性肝癌可切除性评估中的应用.实用肝脏病杂志, 2022, 25(1):96-99.
[13] 孙向征,卢微,李若曼.多层螺旋CT增强扫描诊断肝血管瘤与肝转移癌价值分析.实用肝脏病杂志,2022,25(4):579-582.
[14] Galle PR, Foerster F, Kudo M, et al. Biology and significance of alpha-fetoprotein in hepatocellular carcinoma. Liver Int, 2019,39(12):2214-2229.
[15] Deng H, Kan A, Lyu N,et al. Dual vascular endothelial growth factor receptor and fibroblast growth factor receptor inhibition elicits antitumor immunity and enhances programmed cell death-1 checkpoint blockade in hepatocellular carcinoma. Liver Cancer, 2020,9(3):338-357.
[16] Shigeta K, Datta M, Hato T, et al. Dual programmed death receptor-1 and vascular endothelial growth factor receptor-2 blockade promotes vascular normalization and enhances antitumor immune responses in hepatocellular carcinoma. Hepatology, 2020,71(4):1247-1261.
[17] 毛月琴,张红侠,宋海燕,等.TACE联合毒痰瘀脾虚方治疗原发性肝癌患者临床疗效研究.实用肝脏病杂志,2022,25(6):873-876.
[18] Alzamzamy A, Elsayed H, Abd Elraouf M, et al. Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis C virus-related cirrhotic patients. World J Gastrointest Oncol, 2021,13(6):600-611.
[19] 方勇超,王强,唐权,等.MSCT与MRI动态增强扫描对高血供肝内胆管癌与肝细胞癌的诊断价值分析.实用肝脏病杂志,2020,23(6):885-888.
[20] Ioannou GN, Ioannou GN.HCC surveillance after SVR in patients with F3/F4 fibrosis. J Hepatol,2021,74(2):458-465. |